Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 11/20 | 0.61 |
| ▸ | NPY1R | P25929 | 6/20 | 0.61 |
| ▸ | NPY2R | P49146 | 4/20 | 0.61 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.61 |
| ▸ | MMP2 | P08253 | 1/20 | 0.54 |
| ▸ | GNPAT | O15228 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29630650 | 1.00 | NPY4R (0.61) | NPY4RNPY1RNPY2RNPY5RMMP2 | |
| SCHEMBL30375565 | 1.00 | NPY4R (0.61) | NPY4RNPY1RNPY2RNPY5RMMP2 | |
| SCHEMBL30845381 | 0.99 | NPY4R (0.59) | NPY4RNPY1RNPY2RNPY5RMMP2 | |
| SCHEMBL30958098 | 0.99 | NPY4R (0.59) | NPY4RNPY1RNPY2RNPY5RMMP2 | |
| SCHEMBL30958097 | 0.99 | NPY4R (0.59) | NPY4RNPY1RNPY2RNPY5RMMP2 | |
| SCHEMBL29406322 | 0.99 | NPY4R (0.59) | NPY4RNPY1RNPY2RNPY5RMMP2 | |
| SCHEMBL30565144 | 0.97 | NPY4R (0.59) | NPY4RNPY1RNPY2RNPY5RMMP2 | |
| SCHEMBL30118077 | 0.96 | NPY4R (0.56) | NPY4RNPY1RNPY2RNPY5RGNPAT | |
| SCHEMBL29549393 | 0.96 | NPY4R (0.56) | NPY4RNPY1RNPY2RNPY5RGNPAT | |
| SCHEMBL29406427 | 0.96 | NPY4R (0.56) | NPY4RNPY1RNPY2RNPY5RGNPAT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250327817-A1 | DETECTION OF PREDICTORS OF PREECLAMPSIA | UNIV IOWA RES FOUND (US) | 2025-10-23 | — | — | US | disclosed |
| EP-3237435-B1 | METABOLICALLY STABLE APELIN ANALOGS IN THE TREATMENT OF DISEASE MEDIATED BY THE APELIN RECEPTOR | INST NAT SANTE RECH MED (FR) | 2023-05-24 | — | — | EP | disclosed |